Aristo Bio-Tech and Lifescience (NSE:ARISTO) Total Liabilities: ₹1,033 Mil (As of Mar. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:ARISTO Aristo Bio-Tech and Lifescience Ltd NSE:ARISTO
59 GF Score
Price ₹115.00
View Full Analysis

What is Aristo Bio-Tech and Lifescience Total Liabilities?

Aristo Bio-Tech and Lifescience NSE:ARISTO 59 Total Liabilities is ₹1,033 Mil as of Mar. 2025. GuruFocus rates NSE:ARISTO with a GF Score™ of 59/100.

Aristo Bio-Tech and Lifescience's Total Liabilities for the quarter that ended in Mar. 2025 was ₹1,033 Mil.

Aristo Bio-Tech and Lifescience's quarterly Total Liabilities increased from Mar. 2024 (₹936.78 Mil) to Sep. 2024 (₹1,851.21 Mil) but then declined from Sep. 2024 (₹1,851.21 Mil) to Mar. 2025 (₹1,032.93 Mil).

Aristo Bio-Tech and Lifescience's annual Total Liabilities increased from Mar. 2023 (₹696.74 Mil) to Mar. 2024 (₹936.78 Mil) and increased from Mar. 2024 (₹936.78 Mil) to Mar. 2025 (₹1,032.93 Mil).

Aristo Bio-Tech and Lifescience Total Liabilities Historical Data

* Premium members only.

The historical data trend for Aristo Bio-Tech and Lifescience's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aristo Bio-Tech and Lifescience Total Liabilities Chart

Aristo Bio-Tech and Lifescience Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Total Liabilities
Get a 7-Day Free Trial 680.37 621.36 696.74 936.78 1,032.93

Aristo Bio-Tech and Lifescience Semi-Annual Data
Mar20 Mar21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25
Total Liabilities Get a 7-Day Free Trial Premium Member Only 696.74 958.82 936.78 1,851.21 1,032.93
NSE:ARISTO
59GF Score
Aristo Bio-Tech and Lifescience Ltd NSE:ARISTO
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aristo Bio-Tech and Lifescience Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Aristo Bio-Tech and Lifescience's Total Liabilities for the fiscal year that ended in Mar. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=955.757+(76.4+0.76899999999998
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=1,033

Total Liabilities=Total Assets (A: Mar. 2025 )-Total Equity (A: Mar. 2025 )
=1406.239-373.313
=1,033

Aristo Bio-Tech and Lifescience's Total Liabilities for the quarter that ended in Mar. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=955.757+(76.4+0.76899999999998
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=1,033

Total Liabilities=Total Assets (Q: Mar. 2025 )-Total Equity (Q: Mar. 2025 )
=1406.239-373.313
=1,033

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of ₹1,033 Mil mean?
Aristo Bio-Tech and Lifescience (NSE:ARISTO) has a Total Liabilities of ₹1,033 Mil as of Mar. 2025. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Aristo Bio-Tech and Lifescience and its competitors.
Is Aristo Bio-Tech and Lifescience's Total Liabilities too high?
Aristo Bio-Tech and Lifescience's current Total Liabilities is ₹1,033 Mil. Overall, Aristo Bio-Tech and Lifescience has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does Aristo Bio-Tech and Lifescience's Total Liabilities compare to CTVA and CF?
Aristo Bio-Tech and Lifescience's Total Liabilities of ₹1,033 Mil can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for an Agriculture company?
A good Total Liabilities depends on the Agriculture industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Aristo Bio-Tech and Lifescience and its competitors. Aristo Bio-Tech and Lifescience's current Total Liabilities is ₹1,033 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aristo Bio-Tech and Lifescience stock overvalued right now?
Aristo Bio-Tech and Lifescience (NSE:ARISTO) has a current Total Liabilities of ₹1,033 Mil. The current Total Liabilities is ₹1,033 Mil. Aristo Bio-Tech and Lifescience's overall GF Score™ is 59/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Aristo Bio-Tech and Lifescience (NSE:ARISTO), the current Total Liabilities is ₹1,033 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aristo Bio-Tech and Lifescience Business Description

Address E-24, 25, 26, G.I.D.C, Manjusar, Taluka Savli, Vadodara, GJ, IND, 391775
Aristo Bio-Tech and Lifescience Ltd is an agrochemical company. It is mainly engaged in the manufacturing, formulation, supplying, packaging and job work services of various pesticides. The company exports products like Insecticides, Herbicides, Fungicides, Plant Growth Regulators and a wide variety of other Agrochemicals.
59GF Score

Get the complete analysis for NSE:ARISTO

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹115.00
Price